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876 The Journal of Thoracic and CardioObjective: Long-segment tracheal stenosis is rare, life-threatening, difficult, and
expensive to treat. Management remains controversial. A multidisciplinary tracheal
team was formed in 2000 to deal with a large number of children with airway
problems referred for management. We review the effect of that service, comparing
the era before and after the establishment of the multidisciplinary tracheal team.
Methods: From January 1998 through January 2004, 34 patients with long-segment
tracheal stenosis (21 patients with cardiovascular anomalies) underwent surgical
intervention. Cardiopulmonary bypass was used in all operations. Before the mul-
tidisciplinary tracheal team, pericardial patch tracheoplasty with or without an
autograft technique was the preferred method of repair. After the multidisciplinary
tracheal team, an integrated care plan preferring slide tracheoplasty was initiated,
correcting cardiac lesions simultaneously.
Results: Before the establishment of the multidisciplinary tracheal team, pericardial
patch tracheoplasty was performed in 15 of 19 patients. Twelve patients had a sus-
pended pericardial patch tracheoplasty, 2 (17%) of whom died late after the operation.
Of 3 patients who had had a simple unsuspended patch, 2 (67%) died early after the
operation. Four patients were operated on with the tracheal autograft technique, 2 (50%)
dying early in the postoperative period. After multidisciplinary tracheal team formation,
in the era between 2001 and 2004, 15 patients were operated on with slide tracheoplasty,
and there were 2 (13%) early postoperative deaths. A significant reduction in cost and
duration of stay has been shown both in the intensive care unit and the hospital.
Conclusion: Our data suggest that a formalized multidisciplinary team approach and
a policy of primary slide tracheoplasty are beneficial in the management of children
with long-segment tracheal stenosis.
Long-segment tracheal stenosis (LSTS) in children is rare and potentiallylife-threatening, and the treatment remains controversial. Over the years,we have used a number of therapeutic options.1 Several specialty groupswere involved, with interactions based on a consultation-when-neededpolicy. We had evolved an ad hoc policy involving slide tracheoplasty(STP)1 for short- and medium-length stenosis and, on the basis of the
late 1990s literature,2,3 patch tracheoplasty (PTP) for long or very long stenoses.
Stenting was used for early failure, and tracheal homograft patch repair4 was used for
late recurrence.
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late 2000, we met to review our strategies. We created a
multidisciplinary tracheal team (MDTT) comprising all spe-
cialties involved in caring for such patients. We took the
following decisions:
1. All referrals of children with tracheal problems
would be channeled through the MDTT.
2. Investigations would be carried out according to a
fixed protocol.
3. STP would become our procedure of first choice and
extended to include longer-segment stenosis.
4. Coexistent congenital heart defects would be fixed at
the same operation.
5. PTP would become a second-string strategy. Tra-
cheal homograft repair would be used for recurrent
severe stenosis if stenting failed.
6. Postoperative surveillance would be by means of fiber-
optic bronchoscopy (FOB) and bronchography. Gran-
ulations would be managed with radial balloon dilata-
tion.
7. Members of the team would be cross-skilled (espe-
cially in FOB and stent placement) to facilitate
timely follow-up in the resource-limited system in
which we work.
8. Nurse liaison and lead administrator posts would be
established to improve integration of care pathways
and communication with patients, families, referrers,
and the multiple teams involved. Shared care with
referring units would be encouraged and facilitated.
9. A weekly meeting of the MDTT would be held for
patient and data review.
This article is designed to define the effect of these
changes, implemented in January 2001, by reporting a ret-
rospective 6-year review of our experience for 3 years
before and 3 years after the introduction of the MDTT and
the change of strategies indicated above.
Patients and Methods
Era
The study took place from January 1998 through January 2004, a
3-year period on either side of the establishment of the MDTT in
January 2001.
Patients
Details of the patients are summarized in Table 1. Thirty-four
patients (24 male and 10 female patients) aged less than 16 years
with a primary diagnosis of LSTS were treated. All patients had
stenosis extending for more than two thirds of the length of the
trachea and involving the carina. The median age of the patients
was 131 days (range, 9-5475 days). Thirty-one patients were less
than 1 year of age. There was a high incidence (21/34 [62%]) of
coexistent cardiovascular anomalies. Two patients had absence of
the right lung.
The Journal of ThoraciMethods
A retrospective chart review was undertaken. The patients were
divided for reporting into 2 groups: before the MDTT and after the
MDTT.
For the pre-MDTT group, no fixed protocols existed, and care
was individualized. Surgical intervention was carried out accord-
ing to published methods.2,3,5,6 Postoperatively, endotracheal in-
tubation was used as a temporary stent until the patch was judged,
both subjectively and on FOB, to have become firm.
For the post-MDTT group, care was more structured. STP was
carried out according to standard techniques.1,7,8 Patients were
intubated for a minimum of 5 days, after which they underwent
FOB and bronchography to define timing for extubation. Intrave-
nous antibiotics were given for 7 days after the operation. FOB and
bronchography were repeated after 2 weeks and 6 months and
thereafter as needed.
Statistical Analysis
Data were entered into a Statview (version 5.0; SAS Inc, Cary, NC)
spreadsheet for calculation of descriptive statistics and further analy-
sis. Data between groups were compared with unpaired t tests.
Results
Before the MDTT (1998-2001), pericardial PTP was per-
formed on 15 of 19 patients (Figure 1). Twelve patients had
a suspended pericardial PTP, 2 (17%) of whom died late
after surgical intervention (see below). Of 3 patients who
TABLE 1. The age, sex, and associated cardiovascular
anomalies of patients before and after the establishment of
the multidisciplinary tracheal team in 2001
Pre-MDTT
(n  19)
Post-MDTT
(n  15)
Median age at operation,
wk (range)
18.7 (1.3–104.2) 14.42 (1.8–782.1)
Sex (male/female) 13/6 11/4
Associated anomalies (n) 11 10
PA sling 7 6
ASD 1 1
VSD 1 1
PDA 1 1
A-P window 1 —
Trisomy 21 2 —
Absent right lung 1 1
DORV — 1
Subaortic stenosis — 1
Coarctation of aorta — 1
Type II common
arterial trunk, truncal
valve dysplasia, IAA
— 1
Esophageal atresia 1 —
MDTT, Multidisciplinary tracheal team; PA, pulmonary artery; ASD, atrial
septal defect; VSD, ventricular septal defect; PDA, patent ductus arterio-
sus; A-P, aorta-pulmonary; DORV, double-outlet right ventricle; IAA, inter-
rupted aortic arch.had had a simple unsuspended patch, 2 (67%) died early
c and Cardiovascular Surgery ● Volume 128, Number 6 877
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TSafter the operation. In one patient a fistula from the innom-
inate artery to the trachea formed. This was repaired, but the
patient died later of sepsis and patch dehiscence. The second
patient had untreatable distal malacia and granulations,
causing fatal respiratory insufficiency.
Four patients underwent repair by means of the tracheal
autograft technique. Two (50%) died early postoperatively.
The first had esophageal atresia and hypoplastic left lung.
Autopsy revealed solid lung and severe distal airway mala-
cia, despite satisfactory tracheal reconstruction. The second
patient had trisomy 21 and multiple ventricular septal de-
fects. This patient died of an unrepairable cardiac abnor-
mality. After the formation of the MDTT (2001-2004), 15
Figure 1. The fate of children with LSTS managed fro
MDTT in the year 2001.
TABLE 2. The median, range, and P values for the duration
and the hospital and the duration of endotracheal intubati
Pre-MDTT, med
Duration of stay in ICU (d) 28 (5–130
Duration of endotracheal intubation (d) 17.8 (0.7–4
Duration of stay in HDU (d) 17 (1–130
Total duration of stay in hospital (d) 59 (5–243
ICU cost (£ sterling) 41,208 (8585–
HDU cost (£ sterling) 13,209 (777–1
Total cost of hospital stay (£ sterling) 56,331 (8585–
MDTT, Multidisciplinary tracheal team; ICU, intensive care unit; HDU, higpatients underwent STP, and 2 (13%) died early postoper-
878 The Journal of Thoracic and Cardiovascular Surgery ● Deceatively. Both had severe additional congenital cardiac mal-
formations, and both had treatment withdrawn despite
widely patent major airways, the first for severe distal
bronchomalacia (autopsy revealed complete absence of
bronchial cartilage) and the second for truncal valve regur-
gitation and multiple ventricular septal defects.
Intensive care unit stay was significantly shorter in the
post-MDTT group, as was the total hospital stay (Figure 2).
Duration of endotracheal intubation and stay in the high-
dependency unit were not statistically different (Table 2).
Intensive care unit costs and total hospital costs were
both significantly lower for the post-MDTT patients. The
change in high-dependency unit costs approached statistical
years before to 3 years after the establishment of the
stay in the intensive care unit, the high-dependency unit,
ith ICU, HDU, and total hospital costs
range) Post-MDTT, median (range) P value
7 (2–54) .03
5.2 (1.7–54) .09
5 (1–26) .78
21.5 (10.4–55) .01
210) 12,019 (6868–92,718) .03
0) 3885 (777–20,202) .07
20) 18,401 (13,648–92,718) .01
endency unit.m 3s of
on, w
ian (
)
0.4)
)
)
223,
01,01
324,2significance (Table 2).
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TSCosts of postoperative morbidity are also important. In
the pre-MDTT group a significantly higher percentage of
patients (58% vs 7%) had recurrent stenosis after surgical
intervention. These costs amounted to £20,800 and £4550,
respectively (Figure 3). In the pre-MDTT group significant
granulations were detected in 12 patients, 11 of whom were
stented. In the post-MDTT group only one patient, who
received a temporary stent, had moderate granulations.
Before the MDTT, the average cost of treatment per
patient (n 19) was £77,333. After the MDTT, the average
cost per patient (n  15) was £26,219. This represents a
savings per patient of £51,114.
The median follow-up for the 26 survivors was 38
months (range, 2-57 months). There have been 2 late deaths
(8 and 38 months postoperatively), both in the pre-MDTT
group, from severe distal tracheobronchomalacia.
Discussion
In our hands the combination of STP and multidisciplinary
teamwork has been associated with improved and more
predictable results, reduced morbidity, and simplified man-
agement while reducing cost. We judge STP to be a better
procedure (lower mortality, less stenting, shorter postoper-
ative stay, and fewer granulations) than PTP. Furthermore,
the team approach has maximized the overall efficiency of
the management process.
Do our data justify these inferences? To answer this, we
Figure 2. Box and whisker plots showing the difference
(b) duration of intubation, (c) duration of stay in the high
stay.need first to consider the appropriateness of both the deci-
The Journal of Thoracision to hold and the outcomes of our consensus meetings in
late 2000. As previously reported,1 we had used a wide
variety of surgical repairs for LSTS. Treatment had been
individualized but was heavily influenced by the most re-
cent literature. We had been seduced by the results from
Backer,2 Brown,3 and their associates describing autograft
and PTP, which seemed sensible for patients with long-
segment stenoses extending into the bronchi.
The published literature was not definitive, principally
because of small numbers, single-center reporting, and
the large number of available surgical procedures. Nev-
ertheless, others had concluded that STP was the pre-
ferred option.2,7-14 We have become confident that STP
can be used for almost all cases of LSTS, even those
extending into the bronchus. Since 2001, further support-
ive data have been published.15-20 There seems little
doubt that reconstruction of the trachea with vascularized
tracheal tissue should be superior to the use of devascu-
larized, nontracheal tissue.
The surgeon has been seen as central to outcomes, but we
were well aware that individual proficiency in a particular task
is only one facet of effective team performance.21 Thus the
MDTT was modeled on previous successes in, for example,
transplantation and extracorporeal membrane oxygenation.
The unstructured approach to our patients before 2000 lent
itself to such rationalization. Several blocks to efficiency
were identified: difficulty in integrating specialty groups
) duration of stay (DOS) in the intensive care unit (ICU),
endency unit (HDU), and (d) the total length of hospitalin (a
-depand coordinating admissions, liaising over intensive care
c and Cardiovascular Surgery ● Volume 128, Number 6 879
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arranging and performing FOB (only performed by the
respiratory physician [CW] and the cardiothoracic sur-
geon [MJE] before 2000), and endoscopic tracheal stent-
ing (only performed by the interventional radiologist
[DR] before 2000). Most problems were resolved by
establishing liaison and administration posts, written pro-
tocols, care pathways, and the weekly meeting. The FOB
and stenting issue was more complex. We decided to
implement cross-skills by training others in these tasks.
During the latter part of 2000 and throughout 2001, MJE
learned to implant stents and to perform balloon dilata-
tions and bronchography, and DR and CM (radiographer)
learned to do FOB. Consequently, it became much easier
to arrange follow-up or urgent investigations, contribut-
ing to the reduction in hospital stay and cost. Others22
have shown that providing cross-skills improves team
performance.
The MDTT has had other benefits. For example, there
has been increased referral of patients with many different
airway problems from a progressively wider area. This has
increased our patient population, accelerated our learning
curve, and unified policies supported by regular audit. We
therefore recommend centralization of care and an MDTT
approach for pediatric patients with major airway problems.
We are very proud to be members of the MDTT and believe
we have achieved what Morgan and colleagues23 described as
the 7 dimensions of teamwork: communication, adaptability,
cooperation, acceptance of suggestions or criticism, giving
suggestions or criticism, commitment to a common goal, and
Figure 3. Box and whisker plots showing the differenc
unit (HDU) cost, and (c) total cost.team spirit.
880 The Journal of Thoracic and Cardiovascular Surgery ● DeceLimitations
There are several limitations to this study:
1. It represents a small, short, single-center experience.
2. The design of the study precludes formal comparison
of strategies and is neither prospective nor randomized.
3. The follow-up period is very short. Current percep-
tions of good outcome might be dispelled by time.
4. The effect of era and learning curve might account
for the study findings.
Despite these limitations, we judge our current protocols
for the management of LSTS to be working. The MDTT is
functioning well, and our results with STP are consistent
with those in the literature. The patients who have suc-
cumbed since the introduction of the MDTT have done so
either for cardiac reasons or because of severe distal malacia
and not because of failed airway repairs.
Ideally, there would be specifically designed prospective
randomized studies. In reality, the available patient popula-
tion for such studies is too small, even in our own busy and
active unit. We simply have to apply common sense to the
data to suggest best practice.
Conclusions
Our data suggest that children with LSTS benefit from the
formalized multidisciplinary team approach and a policy of
primary STP.
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The Journal of ThoraciDiscussion
Dr Hermes C. Grillo (Boston, Mass). Zeng and Goldstraw de-
scribed slide tracheoplasty in 1989, with success in one of their 2
patients. In 1994, after our short report of success in 4 consecutive
patients, the method became quite widely applied around the
world, and the advantages over patch tracheoplasty seemed evi-
dent. I can only say “seemed.” The trachea is immediately recon-
structed with tracheal tissue. The result is complete airway stability
at the end of the operation and complete respiratory epithelial
lining right at the outset. As a result, granuloma formation in the
suture lines is negligible. Postoperative intubation and ventilation,
we have found, is generally unnecessary in these patients.
By 2001, we had accumulated a small series of 8 consecutive
successful repairs, to which we have added a few more. By that
time, we found there were 22 patients reported worldwide, and
therefore the experience was growing. Slide tracheoplasty, I think,
continued to show clear advantages over previous patch proce-
dures, and you have pointed out their complexity, complications,
failures, and mortality.
You and your colleagues have added 15 more cases, and the
organization of the multidisciplinary team, I believe, might or
might not have contributed to, as you have also stated today,
improved results over the patch. I say that because the prior
experiences that I have just listed suggest that the substitution of
what seems to be a superior procedure—and I realize that is a
matter of opinion—is most likely the principal factor rather than
the team. Unfortunately, the rarity of these lesions and, at the same
time, these excellent surgical experiences in the last few years
really militate against randomized or prospective series, as you
have indicated.
I would say that the need for a special team would seem to us
to be dictated by institutional imperatives more than anything else.
In our hospital, for example, congenital stenosis is treated by
general thoracic surgeons who have special expertise in tracheal
surgery. They are experienced in diagnostic and interventional
bronchoscopy and direct the preoperative and postoperative care.
Therefore it is a unitary kind of care. The specialized radiologists
and anesthesiologists, of course, play a role, and congenital cardiac
surgeons participate as needed for each individual patient. The
results have been excellent thus far, as indicated.
Also, just to follow up on your last comment, the long-term
follow-up in this small series with the smaller patients has been
excellent. They do grow, and they grow very nicely without
symptoms.
I certainly agree that the anomaly is so rare and so surgically
challenging that patients would indeed be best treated in regional
centers. And it is preferable to treat patients where there is exper-
tise in this type of operation and airway surgery. I am afraid that
is very unlikely to occur in the United States for a number of
obvious reasons.
I only have one minor question, and it is procedural. In our
limited experience, 5 of the 8 patients were extubated in the
operating room, and 3 of the 8 were extubated at 1, 3, and 8 days,
respectively. What is the need for 5 days of routine ventilation with
these patients who have essentially a normal airway when you
finish the operation?
Dr Elliott. Thank you very much, Dr Grillo. It was intimidating
delivering the paper in front of you and having you ask the question.
c and Cardiovascular Surgery ● Volume 128, Number 6 881
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they reflect the philosophy that we have described.
The issue about the period of ventilation was, like all the other
decisions we took at the beginning of the team, a consensus
decision. It did not have a particular value other than that. I am
certain that some of the patients could have been extubated earlier,
and therefore perhaps we need to develop a protocol for that.
However, I do have a caveat, perhaps related to the patient pop-
ulation that we see, which has a very disproportionate load of
associated congenital heart disease. There is a subset that seems to
have been exposed to, by the very repair of their proximal tracheal
stenosis, very severe distal bronchomalacia, as though they have
“auto-PEEP” by the presence of a long-segment stenosis, which,
when it is corrected, exposes severe distal malacia.
Four of the patients who died in this series had this condition.
Furthermore, we now have another patient in exactly the same
position in the intensive care unit since these data were drawn
together. I am very concerned that we do not yet have a mechanism
for identifying this subset. Thus we have been cautious about early
extubation until we can be more certain about the presence or
absence of that distal malacia.
Dr Vaughn A. Starnes (Los Angeles, Calif). Could you define
a long segment for me? I mean, we have seen patients from the
subglottic region down to the carina and actually some recent
children onto the left bronchus. Given the extensive nature of the
disease in some children, where can you apply this particular
technique of slide tracheoplasty?
Dr Elliott. First question first. I do not know of a good
definition of long-segment tracheal stenosis, but my colleague, Dr
Kocyildirim, is presenting what I hope will be such a definition at
the American Society of Radiology in Charleston later this week
on the basis of bronchographic measurements.
For the purposes of this population of patients, we have defined
long-segment stenosis as more than two thirds of the trachea. We
agree that many of those do extend on to the bronchus; in fact, that
was why we migrated toward patch tracheoplasty in the 1990s.
I do not now think that a slide tracheoplasty needs to be limited at
all. Some of these patients have had carina-to-right-main-bronchus
slide tracheoplasties without any problem. I was worried about devas-
cularization of the trachea, but in the small baby it really does not
seem to be a major issue.
Dr Carl L. Backer (Chicago, Ill). I would like to congratulate
Martin and his colleagues on their excellent results with infants
with long-segment congenital tracheal stenosis. Our center has had
a strong interest in these patients for many years, and our series
now includes more than 60 infants and children. I have a few
comments and questions.
I believe the question that Martin has asked is as follows: Is it
the team, is it the technique, or is it both? In trying to answer this
question, I hate to disagree with Dr Grillo, but I believe that the
team approach is a significant key to your success. Our institution
has essentially had a de facto tracheal surgery team, and we have
been very careful to limit the number of people who actually care
for these critically ill patients. I agree with and encourage the
creation of dedicated teams to take care of these patients.
The second part of the question concerns the technique. We are
all searching for the Holy Grail of the ideal operation for long-
882 The Journal of Thoracic and Cardiovascular Surgery ● Decesegment congenital tracheal stenosis. I would submit, even if you
look just at our little area of the Midwest, that in the hands of
dedicated teams, different techniques have led to similar results.
Dr John Brown has done 23 pericardial tracheoplasties with 3
deaths. Dr Chuck Huddleston uses the cartilage tracheoplasty,
which I have used as a rescue operation. He reported on 10 patients
with 1 death. Our group now has 19 autografts with 3 deaths.
Finally, Dr Peter Manning, who is right behind me, reported 11
slide tracheoplasties with 2 deaths. That is just in the Midwest. At
these 4 institutions, you have 4 different techniques with almost
identical results to yours with the slide tracheoplasty.
I have 3 questions. The first question relates to the technique of
the operation. I assume that you used cardiopulmonary bypass in
all of these operations?
Dr Elliott. All of them had bypass.
Dr Backer. My second question relates to a paper presented at
the Southern Thoracic Surgical Society that recommended the use
of extracorporeal membrane oxygenation (ECMO) postoperatively
in these patients. Did you use ECMO postoperatively in any of
your patients, and what do you think about that strategy?
Dr Elliott. We used ECMO in none postoperatively and 3
preoperatively. We have used ECMO as a resuscitative maneuver
for patients when they cannot be ventilated. The other marginally
ventilatable patients have been managed with helium ventilation,
which can keep a child going for quite a long time until you can get
them onto some form of support.
Dr Backer. My final question relates to the tracheal homograft.
It was based on your very encouraging results with that technique
that we started using the tracheal autograft technique in 1996. I
wondered if you could make a few comments about your use of the
tracheal homograft for rescue operations.
Dr Elliott. We still use tracheal homograft repair for severe
recurrence. Two patients in the patch tracheoplasty series have
ended up with secondary operations with tracheal homograft re-
pair. We have relegated tracheal homograft repair, if you like, to a
salvage operation and for patients referred from elsewhere who
have recurrent severe stenosis. We always counsel the patients
who we have either stented or who arrive with stents that they
might in the future require further tracheal surgery, which would
probably be with a tracheal homograft.
Dr Peter B. Manning (Cincinnati, Ohio). This is just an
excellent series. As we have discussed, our experience mirrors
yours. We have had 29 tracheal reconstructions using bypass, and
the last 22 have been slides, and we have been very pleased with
the results. It is a very versatile technique.
Your experience is probably like ours; when you start to get a
name for yourself with this, you start to get more complex patients.
We found the slide to be very versatile, even in patients who have
been operated on before, either with tracheal reconstructions or
with a tracheostomy. Would you comment about your experience
with both of those problems? If you have seen them, how do you
deal with the tracheostomy if a patient already has one?
Dr Elliott. Well, if they come with a tracheostomy, then we
would try and get everything fixed at the same time and take the
tracheostomy out at the operation.
And yes, we use the slide tracheoplasty if people have had
operations, including one of Richard’s [Jonas] old patients.
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